Prenatal Multivitamin Use and Genotype Are Associated with Newborn Cord Blood DNA Methylation.

BACKGROUND

Fetal development involves cellular differentiation and epigenetic changes-complex processes that are sensitive to environmental factors. Maternal nutrient levels during pregnancy affect development, and methylene tetrahydrofolate reductase () is important for processing the nutrient folate.

HYPOTHESIS

We hypothesize that supplement intake before pregnancy and maternal genotype are associated with DNA methylation in newborns.

METHODS

In the pregnancy cohort, Early Autism Risk Longitudinal Investigation (EARLI), health history, and genotype information was obtained (n = 249 families). Cord blood DNA methylation (n = 130) was measured using the Illumina HumanMethylation450k array and global DNA methylation levels were computed over 455,698 sites. Supplement use preconception and during pregnancy were surveyed at visits during pregnancy. We evaluated associations between maternal preconception supplement intake and global DNA methylation or DNA methylation density distributions of newborn cord blood, stratified by the presence of a variant maternal C677T allele.

RESULTS

Maternal preconceptional multivitamin intake was associated with cord blood methylation, dependent on maternal genotype (interaction term = 0.013). For mothers without the variant allele, multivitamin intake was associated with 0.96% (95% CI: 0.09, 1.83) higher global cord blood methylation ( = 0.04) and was also associated with the cumulative density distribution of methylation ( = 0.03). For mothers with at least one variant allele, multivitamin intake had a null -0.06% (95% CI: -0.45, 0.33) association with global cord blood DNA methylation, and was not associated with the cumulative density distribution ( = 0.37).

CONCLUSIONS

We observed that cord blood DNA methylation was associated with maternal supplement exposure preconception and maternal genotype. Genetic context should be considered when assessing DNA methylation effects of modifiable risk factors around the time of pregnancy.